G. Todd Milne
About G. Todd Milne
G. Todd Milne serves as the Chief Operating Officer at Tisento Therapeutics, a position he has held since 2023. He has extensive experience in the pharmaceutical and biotechnology sectors, having worked at Cyclerion, Ironwood Pharmaceuticals, and Dana-Farber Cancer Institute, among others.
Current Role at Tisento Therapeutics
G. Todd Milne serves as the Chief Operating Officer at Tisento Therapeutics, a position he has held since 2023. In this role, he is responsible for overseeing the company's operations and strategic initiatives. His leadership contributes to the advancement of Tisento's mission in the biotechnology sector, particularly in developing innovative therapeutic solutions.
Previous Experience at Cyclerion Therapeutics
Milne has a significant history with Cyclerion Therapeutics, where he held multiple roles. He worked as a Distinguished Research Fellow from 2019 to 2021, focusing on research initiatives. Following this, he served as Vice President of Corporate Development from 2021 to 2022, and later as Senior Vice President of External Innovation from 2022 to 2023. His tenure at Cyclerion spanned four years, during which he contributed to various strategic and research-oriented projects.
Career at Ironwood Pharmaceuticals
Milne co-founded Ironwood Pharmaceuticals and served as the Vice President of sGC R&D from 1998 to 2019. His 21-year career at Ironwood involved leading research and development efforts, contributing to the company's growth and success in the pharmaceutical industry. His extensive experience in drug development has shaped his expertise in the field.
Educational Background
Milne earned his Bachelor of Science degree in Molecular Biophysics and Biochemistry from Yale University, studying from 1985 to 1989. He furthered his education at Harvard University, where he obtained a Doctor of Philosophy in Microbiology from 1989 to 1995. His academic background provides a strong foundation for his career in biotechnology and pharmaceuticals.
Research Experience at Dana-Farber Cancer Institute and Whitehead Institute
Milne's early research experience includes a six-year tenure as a graduate student at Dana-Farber Cancer Institute from 1989 to 1995, where he engaged in significant research projects. Afterward, he worked as a postdoctoral fellow at the Whitehead Institute from 1995 to 1998, further developing his research skills and expertise in the life sciences.